Sponsor-Investigators

Oana Danciu

BTCRC-BRE15-016

A Single Arm Phase II Study of Palbociclib in Combination with Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016

Status

Closed

Cancer Types

Breast

Locations